Stig Wergeland

Bergen, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 72 publications

Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis.

Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis.

Journal: The New England journal of medicine

Published: July 01, 2026

Between-hospital variation in discontinuation of treatment with dimethyl fumarate in multiple sclerosis.

Between-hospital variation in discontinuation of treatment with dimethyl fumarate in multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: May 12, 2026

Regional patterns of grey matter volume decline in relapsing-remitting multiple sclerosis relative to healthy ageing.

Regional patterns of grey matter volume decline in relapsing-remitting multiple sclerosis relative to healthy ageing.

Journal: NeuroImage

Published: May 11, 2026

Intrathecal Mesenchymal Stem Cells in Progressive Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial (SMART-MS).

Intrathecal Mesenchymal Stem Cells in Progressive Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial (SMART-MS).

Journal: Neurology

Published: May 04, 2026

Alpha-linolenic acid associations with disability and brain volume in multiple sclerosis: a brief replication report.

Alpha-linolenic acid associations with disability and brain volume in multiple sclerosis: a brief replication report.

Journal: Frontiers in neurology

Published: January 26, 2026

Low risk of severe COVID-19 in vaccinated people with multiple sclerosis: a nationwide Norwegian study.

Low risk of severe COVID-19 in vaccinated people with multiple sclerosis: a nationwide Norwegian study.

Journal: BMJ neurology open

Published: January 13, 2026

Revised diagnostic criteria for multiple sclerosis.

Revised diagnostic criteria for multiple sclerosis.

Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Published: December 18, 2025

Correction: Revised diagnostic criteria for multiple sclerosis

Correction: Revised diagnostic criteria for multiple sclerosis

Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Published: December 18, 2025

Normative Modelling of Brain Volume in Multiple Sclerosis.

Normative Modelling of Brain Volume in Multiple Sclerosis.

Journal: medRxiv : the preprint server for health sciences

Published: September 26, 2025

Accelerated grey matter degeneration in relapsing remitting multiple sclerosis.

Accelerated grey matter degeneration in relapsing remitting multiple sclerosis.

Journal: medRxiv : the preprint server for health sciences

Published: July 09, 2025

Effect of early highly effective treatment compared to an escalating treatment strategy in multiple sclerosis.

Effect of early highly effective treatment compared to an escalating treatment strategy in multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: June 17, 2025

Comparative effectiveness of rituximab and cladribine in relapsing-remitting multiple sclerosis: A target trial emulation.

Comparative effectiveness of rituximab and cladribine in relapsing-remitting multiple sclerosis: A target trial emulation.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: May 26, 2025

Showing 1-12 of 72

Last Updated: 09/26/2026